Glycine is an amino acid involved in dozens of bodily functions — from collagen synthesis to blood sugar regulation to nerve signalling. Clinical research has identified meaningful benefits in two areas in particular: sleep quality and metabolic health. This article walks through the evidence, from animal lifespan studies to human clinical trials, and explains the mechanisms, food sources, dosing considerations, and safety profile.
As with all supplements, the decision to supplement is an individual one that depends on a person's health context, diet, and goals. The evidence below describes what studies have found; it is not a recommendation to supplement.
Table of Contents
- Lifespan Research in Animal Models
- What Glycine Does in the Body
- Benefits with Stronger Evidence
- Potential Benefits Needing Further Exploration
- Sources, Supplements, Safety
- Reference List
Lifespan Research in Animal Models
One of the more intriguing findings in glycine research concerns lifespan extension in rodents — and the mechanisms behind it point to some interesting biology worth understanding.
Researchers have known for decades that diets low in methionine can extend the lifespan of rodents. Methionine is an amino acid — one of the building blocks of proteins. When it is broken down in the body, one of the products is homocysteine, another amino acid. When homocysteine levels are too high, this correlates with increased risks for certain health problems, including heart disease.
Glycine appears to reduce the toxic effects of excess methionine in mice [1]. This sparked a scientific question: could boosting glycine intake produce a similar effect to restricting methionine — and could that extend lifespan?
This hypothesis was tested through the Interventions Testing Program, an initiative funded by the National Institute on Aging in the U.S. The programme's goal is to identify substances that could extend lifespan or improve health as we age, using rigorous, multi-site experimental design. Researchers administered glycine as a dietary supplement to mice across three independent testing sites.
The results were encouraging. Glycine produced a small but statistically significant lifespan increase of approximately 4–6% on average across the three sites [1].
At least two mechanisms appear to be involved. The first is that glycine helps counteract excess methionine — it seems to participate in breaking it down and clearing it from the body. Evidence also suggests that glycine can activate autophagy [2].
Autophagy is the process by which cells break down and remove damaged or dysfunctional components — analogous to a cellular recycling and waste-clearance system. It is a crucial process that maintains cellular health and has been associated with healthy ageing across many model organisms.
It is important to note that these are animal studies. Human lifespan research on glycine has not yet been conducted, and translating rodent findings to humans requires caution. The animal data, however, is a useful pointer to the mechanisms through which glycine may support cellular health in humans.
What Glycine Does in the Body
To understand why glycine may produce these effects, it helps to appreciate the range of functions it plays in normal physiology.
Glycine is an amino acid that helps build proteins throughout the body. It is one of the principal ingredients in collagen — the most abundant protein in the human body. Collagen provides structural integrity in tissues including skin, bones, tendons, and blood vessels. Glycine is also incorporated into other important molecules that contribute to muscle function, oxygen transport in the blood, protection against oxidative stress, and fat digestion.
Beyond structural roles, glycine participates in the regulation of blood sugar and immune response. It plays a role in removing toxins from the body, partly through its contribution to glutathione synthesis (see below). And it helps modulate nerve signals — acting as an inhibitory neurotransmitter in certain parts of the nervous system.
Despite being involved in so many important functions, glycine is not classified as an essential amino acid because the body can synthesise it. However, evidence suggests that endogenous synthesis alone may not be sufficient to maintain optimal levels — dietary and supplemental glycine may be necessary to make up the shortfall [3]. A 2022 review estimated a daily requirement of approximately 1.5–3 g beyond what the body produces.
Benefits with Stronger Evidence
Two areas stand out for the strength and consistency of the human clinical evidence.
1. Sleep Quality
The sleep evidence for glycine is particularly robust given that the effects have been replicated across multiple independent studies using both subjective and objective measures.
A small, double-blind study published in 2006 examined the impact of glycine supplements on sleep quality in people who reported difficulty sleeping. Participants took either a placebo or glycine before bed and completed a questionnaire the following morning. The glycine group reported significantly improved ratings of liveliness and clear-headedness, and reduced feelings of fatigue [4].
A follow-up study added objective sleep monitoring alongside the subjective reports. Participants taking glycine reported better sleep and less daytime sleepiness — findings confirmed by the monitoring data: they fell asleep faster, reached deep (slow-wave) sleep more quickly, and performed better on memory tests the next day [5].
Notably, glycine did not alter sleep architecture [5]. This means the normal sequence and proportion of sleep stages remained intact. Many prescription sleep medications disrupt sleep architecture, which is often why people feel groggy and less mentally alert the following day [5]. Glycine appears to support sleep onset and depth without this drawback.
A third study used a mild sleep restriction protocol, reducing participants' normal sleep time by 25% for three consecutive nights while they took glycine or placebo. Measurements of daytime sleepiness and cognitive performance showed that the glycine group had meaningfully reduced fatigue and sleepiness compared to placebo [6].
The mechanism appears to involve body temperature regulation. A rodent study found that glycine influences the biological clock by triggering increased blood flow to the skin, which causes core body temperature to fall [7]. A drop in core body temperature is a normal and necessary signal for the onset of sleep — this is why a warm shower before bed (which raises skin temperature briefly, then causes it to fall on stepping out) can make it easier to fall asleep. Glycine appears to promote the same cooling effect pharmacologically.
The clinical significance of this evidence should not be understated. Poor sleep quality is associated with significantly increased risks of all-cause mortality, heart attacks, and strokes [8]. Interventions that durably improve sleep quality without disrupting sleep architecture represent a meaningful benefit to long-term health.
From the MicroVitamin range
Sleep by Dr Brad contains glycine 2,400 mg — within the dose range used in the clinical sleep studies described above — alongside melatonin 300 mcg and magnesium bisglycinate.
2. Metabolic Health
The second area where the evidence is compelling is metabolic health — the body's ability to efficiently process, store, and use energy from food. This encompasses blood sugar regulation, insulin sensitivity, body composition, oxidative stress, and inflammation.
One small clinical study examined glycine in individuals with elevated risk of developing type 2 diabetes. Glycine supplementation increased post-meal insulin secretion, improving the body's ability to process carbohydrates from food [9]. This suggests a potential role in supporting insulin sensitivity.
A rodent study explored effects on body composition during caloric restriction. Mice receiving glycine burned more fat and retained more muscle mass than control mice on the same restricted diet [10] — a finding consistent with glycine's known role in muscle protein synthesis and energy substrate utilisation.
Both studies point to a positive effect on energy metabolism, though larger human trials are needed to confirm the magnitude and generalisability of these findings.
Two further studies focus on protecting against the damage caused when metabolic health is impaired. Obesity and type 2 diabetes generate chronic oxidative stress and inflammation — excess free radicals and pro-inflammatory cytokines that damage tissues throughout the body.
In a three-month randomised trial in individuals with metabolic syndrome, those receiving glycine showed significant reductions in markers of oxidative stress compared to placebo [11]. This is mechanistically plausible: glycine is one of three amino acids (alongside cysteine and glutamate) required for the synthesis of glutathione, the body's most important endogenous antioxidant. Blood pressure also fell meaningfully in the glycine group — specifically in male participants — which is relevant to cardiovascular risk [11].
On inflammation, research in patients with obesity and type 2 diabetes has shown that glycine decreases circulating pro-inflammatory markers and increases anti-inflammatory signalling molecules [12]. Chronic low-grade inflammation is a driver of cardiovascular disease, metabolic dysfunction, and accelerated tissue ageing — so this finding has implications beyond metabolic health alone.
Potential Benefits Needing Further Exploration
Beyond sleep and metabolic health, there is promising research pointing to further effects of glycine. Two areas are worth reviewing before considering dosing.
3. Heart Health
The blood pressure findings noted above are already relevant to cardiovascular risk. Researchers have also explored glycine's relationship with heart health more directly.
One large prospective analysis examined over 4,000 patients with suspected coronary heart disease over a follow-up period of approximately seven years. Researchers measured blood glycine levels and tracked the incidence of heart attacks. An inverse relationship emerged: the lower a patient's glycine levels, the higher the likelihood of a heart attack [13].
This cohort study establishes association, not causation. A separate analysis approached causality through a Mendelian randomisation design — examining a large genetic database for individuals carrying genetic variants naturally associated with higher glycine levels. These individuals also had better cardiovascular outcomes, providing evidence consistent with a causal protective effect of higher glycine levels on heart health [14]. Part of the benefit is thought to be mediated by lower blood pressure [14].
The glycine–heart health relationship likely involves multiple pathways: lower blood pressure, reduced oxidative stress, and reduced inflammation are all plausible mediators. Prospective randomised controlled trials are needed to confirm these mechanisms and quantify the clinical benefit.
4. Brain Function
Glycine acts as a co-agonist at the NMDA receptor — a key glutamate receptor in the brain that plays a central role in learning, memory, and synaptic plasticity. The NMDA receptor requires simultaneous binding of both glycine and glutamate to activate; glycine is therefore a necessary enabling signal for this receptor's function.
Dysfunction of NMDA receptors is implicated in several neuropsychiatric conditions. A case-control study found that patients with schizophrenia had significantly lower glycine levels in blood compared to healthy controls. The same pattern was observed in patients with major depression [15].
A small clinical trial added high-dose glycine to standard antipsychotic treatment in patients with schizophrenia. The addition of glycine produced a 23% reduction in negative symptoms of schizophrenia [16]. While this is a preliminary finding that requires replication in larger trials, it is mechanistically consistent with NMDA receptor hypofunction as a contributor to negative symptoms.
Sources, Supplements, Safety
The evidence above represents a cross-section of the areas where glycine is showing promise. The practical questions — how much, where to get it, and whether supplementation is safe — are addressed below.
How much glycine is needed? The body synthesises glycine, but evidence suggests endogenous production alone may not meet physiological demands. Sleep studies typically use 3 g per day. A 2022 review recommended an intake of approximately 1.5–3 g per day from diet and/or supplements to meet overall physiological needs [3].
Food sources. Glycine is found in highest concentrations in animal products — particularly collagen-rich tissues such as skin, cartilage, and connective tissue. Bone broth is a concentrated dietary source. Some glycine is also found in legumes, nuts, and seeds, though concentrations are substantially lower than in animal-derived sources.
Supplement form. In supplements, glycine is available in a free amino acid form. It is tasteless, water-soluble, and readily absorbed. It is commonly available as a standalone powder or in combined formulations.
Safety. Glycine is classified as generally recognised as safe (GRAS) by the U.S. Food and Drug Administration. Clinical trials examining supplementation at doses of approximately 3 g per day have not reported concerning adverse effects. As an amino acid naturally produced in the body and consumed in the diet daily, it has a well-established tolerability record at typical supplemental doses. Higher doses (up to 15 g/day) have been used in some psychiatric research without significant safety signals, though standard supplemental doses are in the 3 g range.
Taken together, the evidence-based case for glycine supplementation rests on a favourable benefit-to-risk ratio. The safety profile is consistently good at standard doses. The strongest clinical evidence is for sleep quality improvement — with multiple randomised controlled trials demonstrating benefits in sleep onset, deep sleep duration, and daytime function, without disruption to normal sleep architecture. Secondary evidence supports roles in metabolic health, cardiovascular function, and brain chemistry, with the caveat that larger confirmatory trials are still needed in several of these areas.
Reference List
1. https://pmc.ncbi.nlm.nih.gov/articles/PMC6516426/
2. https://pubmed.ncbi.nlm.nih.gov/37004845/
3. https://www.mdpi.com/2813-2475/3/2/16
4. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1479-8425.2006.00193.x
5. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1479-8425.2007.00262.x
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC3328957/
7. https://www.nature.com/articles/npp2014326
8. https://pubmed.ncbi.nlm.nih.gov/28889101/
9. https://pubmed.ncbi.nlm.nih.gov/11456285/
10. https://www.sciencedirect.com/science/article/abs/pii/S0261561415002411
11. https://pubmed.ncbi.nlm.nih.gov/24144057/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC10379184/
13. https://www.ahajournals.org/doi/10.1161/jaha.115.002621
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC6400990/
